Cargando…

Montreal cognitive assessment in primary sjogren’s syndrome: A brief screening tool

OBJECTIVES: To use the Montreal Cognitive Assessment (MoCA) test to assess the subclinical cognitive impairment in patients with Primary Sjögren’s Syndrome (PSS) and assess the correlation of MoCA results with magnetic resonance imaging (MRI) findings in these patients. METHODS: The MoCA test was pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kurtuluş, Fatma, Çay, Hasan F., Parlak, Eda, Yaman, Aylin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Riyadh : Armed Forces Hospital 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015506/ https://www.ncbi.nlm.nih.gov/pubmed/31380819 http://dx.doi.org/10.17712/nsj.2019.3.20180027

Ejemplares similares

The Beijing version of the montreal cognitive assessment as a brief screening tool for mild cognitive impairment: a community-based study
por: Yu, Jing, et al.
Publicado: (2012)

Evaluation of the Montreal Cognitive Assessment as a screening tool for cognitive dysfunction in SLE
por: Raghunath, Sudha, et al.
Publicado: (2021)

Therapeutic and prognostic features in myasthenia gravis patients followed in a tertiary neuromuscular diseases center in Turkey
por: Yaman, Aylin, et al.
Publicado: (2023)

The Montreal cognitive assessment as a cognitive screening tool in sickle cell disease: Associations with clinically significant cognitive domains
por: Early, Macy L., et al.
Publicado: (2022)

The Montreal Cognitive Assessment Test: A Useful Tool in Screening of Cognitive Impairment in Patients With Systemic Lupus Erythematosus
por: Paez-Venegas, Nicolas, et al.
Publicado: (2019)

Screening for brain fog: Is the montreal cognitive assessment an effective screening tool for neurocognitive complaints post-COVID-19?
por: Lynch, Sean, et al.
Publicado: (2022)

Montreal Cognitive Assessment — Single Cutoff Achieves Screening Purpose
por: Yeung, Pui Yu, et al.
Publicado: (2020)

(41) Screening for Brain Fog: Is the Montreal Cognitive Assessment an Effective Screening Tool for Neurocognitive complaints Post-COVID-19?
por: Lynch, Sean T., et al.
Publicado: (2022)

Cognitive screening for adult psychiatric outpatients: Comparison of the Cognivue(®) to the Montreal Cognitive Assessment
por: Rose, Amanda F, et al.
Publicado: (2021)

Cognitive Dysfunction and Dementia in Primary Sjögren's Syndrome
por: Blanc, Frederic, et al.
Publicado: (2013)

The Screening Accuracy of a Visually Based Montreal Cognitive Assessment Tool for Older Adult Hearing Aid Users
por: Utoomprurkporn, Nattawan, et al.
Publicado: (2021)

Montreal cognitive assessment reflects cognitive reserve
por: Kang, Jae Myeong, et al.
Publicado: (2018)

Comparison of Rapid Cognitive Screen against Montreal Cognitive Assessment in screening for cognitive impairment in the old and old‐old
por: Chen, Matthew Zhixuan, et al.
Publicado: (2022)

Response to: Comment on “Choroidal Thickness in Patients with Mild Cognitive Impairment and Alzheimer's Type Dementia”
por: Bulut, Mehmet, et al.
Publicado: (2016)

Choroidal Thickness in Patients with Mild Cognitive Impairment and Alzheimer's Type Dementia
por: Bulut, Mehmet, et al.
Publicado: (2016)

Response to: Comment on “Choroidal Thickness in Patients with Mild Cognitive Impairment and Alzheimer's Type Dementia”
por: Bulut, Mehmet, et al.
Publicado: (2016)

Validation of the Argentine version of the Montreal Cognitive Assessment Test (MOCA): A screening tool for Mild Cognitive Impairment and Mild Dementia in Elderly
por: Serrano, Cecilia M., et al.
Publicado: (2020)

Brief Montreal-Toulouse Language Assessment Battery: adaptation and content validity
por: Altmann, Raira Fernanda, et al.
Publicado: (2020)

DEVELOPMENT OF A SWEDISH SHORT VERSION OF THE MONTREAL COGNITIVE ASSESSMENT FOR COGNITIVE SCREENING IN PATIENTS WITH STROKE
por: ABZHANDADZE, Tamar, et al.
Publicado: (2023)

Longitudinal Measurement Properties of the Montreal Cognitive Assessment
por: Andersson, Björn, et al.
Publicado: (2021)

Ischemia modified albumin is an indicator of oxidative stress in multiple sclerosis
por: Aydin, Ozgur, et al.
Publicado: (2014)

Using the Montreal Cognitive Assessment Scale to screen for dementia in Chinese patients with Parkinson's Disease
por: CHEN, Ling, et al.
Publicado: (2013)

Correction to: Brief Montreal-Toulouse Language Assessment Battery: adaptation and content validity
por: Altmann, Raira Fernanda, et al.
Publicado: (2020)

Feasibility of Cognitive Functions Screened With the Montreal Cognitive Assessment in Determining ADL Dependence Early After Stroke
por: Abzhandadze, Tamar, et al.
Publicado: (2018)

Comparison of the Greek Version of the Quick Mild Cognitive Impairment Screen and Montreal Cognitive Assessment in Older Adults
por: Messinis, Lambros, et al.
Publicado: (2022)

The reliability and validity of the European League Against Rheumatism Sjögren Syndrome Patient Reported Index in patients with primary Sjögren syndrome: A Turkish version study
por: Gür Kabul, Elif, et al.
Publicado: (2020)

Cognitive Function in Primary Sjögren’s Syndrome: A Systematic Review
por: Manzo, Ciro, et al.
Publicado: (2019)

Proteomic analysis of saliva: a unique tool to distinguish primary Sjögren's syndrome from secondary Sjögren's syndrome and other sicca syndromes
por: Baldini, Chiara, et al.
Publicado: (2011)

Comparison of Alternate and Original Items on the Montreal Cognitive Assessment
por: Lebedeva, Elena, et al.
Publicado: (2016)

Concordance of the Montreal cognitive assessment with standard neuropsychological measures
por: Vogel, Sally J., et al.
Publicado: (2015)

Comparison of Oxford Cognitive Screen and Montreal Cognitive Assessment feasibility in the stroke unit setting. A pilot study
por: Brambilla, Michela, et al.
Publicado: (2021)

Montreal Cognitive Assessment as Screening Measure for Mild and Major Neurocognitive Disorder in a Chilean Population
por: Bello-Lepe, Sebastian, et al.
Publicado: (2020)

Development and preliminary validation of the Sjögren’s Tool for Assessing Response (STAR): a consensual composite score for assessing treatment effect in primary Sjögren’s syndrome
por: Seror, Raphaele, et al.
Publicado: (2022)

Montreal Cognitive Assessment of cognitive dysfunction after basal ganglia stroke
por: Ye, Baoye, et al.
Publicado: (2022)

Cognition, depression, fatigue, and quality of life in primary Sjögren's syndrome: correlations
por: Koçer, Belgin, et al.
Publicado: (2016)

Nephrocalcinosis in primary Sjögren's syndrome
por: Gharbi, Chems, et al.
Publicado: (2014)

Biomarkers for Primary Sjögren’s Syndrome
por: Chen, Weiqian, et al.
Publicado: (2015)

Imaging in Primary Sjögren’s Syndrome
por: van Ginkel, Martha S., et al.
Publicado: (2020)

ACPA-positive primary Sjögren's syndrome: true primary or rheumatoid arthritis-associated Sjögren's syndrome?
por: Payet, J, et al.
Publicado: (2015)

Splitting of a Dexamethasone Implant (Ozurdex) following the Injection
por: Donmez, Oya, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ihaccukadq7tkkon8ccplh1vms